TiGenix: A Deeply Undervalued Stem Cell Company With Upcoming Catalysts – Nasdaq
Nasdaq |
TiGenix: A Deeply Undervalued Stem Cell Company With Upcoming Catalysts
Nasdaq TiGenix ( TGXSF ) — listed on Euronext Brussels — is a leading but little known Belgian cell therapy biotech with an advanced adipose-derived allogeneic stem cell product platform in various clinical stages. TiGenix also has a commercialized product … |
